Literature DB >> 7663405

Interaction of indole derivatives with monoamine oxidase A and B. Studies on the structure-inhibitory activity relationship.

A E Medvedev1, A S Ivanov, N S Kamyshanskaya, A Z Kirkel, T A Moskvitina, V Z Gorkin, N Y Li.   

Abstract

Indole and isatin (2,3-dioxindole) analogues were studied as inhibitors of MAO-A and B. They exhibited reversible and competitive MAO inhibition. Three dimensional structures of the compounds tested were constructed and minimized using PC-based molecular graphic software. The QSAR analysis revealed the requirement of co-planar structure of substituents at C2 and C3 of indole ring for selective MAO-A inhibition, whilst type of bond was less essential. The presence of hydroxy group at C5 of isatin increased selectivity of MAO-A inhibition, however simultaneous insertion of substituents into both positions of indole ring (5-hydroxy-2-phenylindole) led to a decrease of MAO-A inhibition. The planar molecules demonstrating potent MAO-A inhibition have the average sizes 7 A in length and 6 A in width. The MAO B inhibition also depended on the sizes of planar molecules however distribution of electron density in the molecules was another precondition for the selective inhibition of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7663405

Source DB:  PubMed          Journal:  Biochem Mol Biol Int        ISSN: 1039-9712


  9 in total

1.  Charge-transfer interactions in the inhibition of MAO-A by phenylisopropylamines--a QSAR study.

Authors:  Gabriel Vallejos; Marcos Caroli Rezende; Bruce K Cassels
Journal:  J Comput Aided Mol Des       Date:  2002-02       Impact factor: 3.686

Review 2.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

3.  Oxidative Cyclization of 4-(2-Aminophenyl)-4-oxo-2-phenylbutanenitriles into 2-(3-Oxoindolin-2-ylidene)acetonitriles.

Authors:  Nicolai A Aksenov; Alexander V Aksenov; Lidiya A Prityko; Dmitrii A Aksenov; Daria S Aksenova; Mezvah A Nobi; Michael Rubin
Journal:  ACS Omega       Date:  2022-04-15

4.  One-Pot Synthesis of (E)-2-(3-Oxoindolin-2-ylidene)-2-arylacetonitriles.

Authors:  Nicolai A Aksenov; Alexander V Aksenov; Igor A Kurenkov; Nikita K Kirillov; Dmitrii A Aksenov; Nikolai A Arutiunov; Daria S Aksenova; Michael Rubin
Journal:  Molecules       Date:  2022-04-28       Impact factor: 4.927

5.  Computer visualisation of the active site of monoamine oxidase-A by means of selective inhibitors.

Authors:  Alexei E Medvedev; Alexis S Ivanov; Alexander V Veselovsky
Journal:  Inflammopharmacology       Date:  2003       Impact factor: 4.473

6.  Benzo[b]tiophen-3-ol derivatives as effective inhibitors of human monoamine oxidase: design, synthesis, and biological activity.

Authors:  Paolo Guglielmi; Daniela Secci; Anél Petzer; Donatella Bagetta; Paola Chimenti; Giulia Rotondi; Claudio Ferrante; Lucia Recinella; Sheila Leone; Stefano Alcaro; Gokhan Zengin; Jacobus P Petzer; Francesco Ortuso; Simone Carradori
Journal:  J Enzyme Inhib Med Chem       Date:  2019-12       Impact factor: 5.051

Review 7.  Monoamine Oxidase (MAO) as a Potential Target for Anticancer Drug Design and Development.

Authors:  Reem Aljanabi; Lina Alsous; Dima A Sabbah; Halise Inci Gul; Mustafa Gul; Sanaa K Bardaweel
Journal:  Molecules       Date:  2021-10-04       Impact factor: 4.411

8.  Unexpected cyclization of ortho-nitrochalcones into 2-alkylideneindolin-3-ones.

Authors:  Nicolai A Aksenov; Dmitrii A Aksenov; Nikolai A Arutiunov; Daria S Aksenova; Alexander V Aksenov; Michael Rubin
Journal:  RSC Adv       Date:  2020-05-14       Impact factor: 3.361

9.  Mechanistic studies of anti-hyperpigmentary compounds: elucidating their inhibitory and regulatory actions.

Authors:  Rosanna Y Y Lam; Zhi-Xiu Lin; Elena V Sviderskaya; Christopher H K Cheng
Journal:  Int J Mol Sci       Date:  2014-08-21       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.